Physician profile
Sara Geiger
NPI 1326698705
$5,473.35
in general payments reported to CMS, 2019-2025
10 companies · $703 in 2025
The $703 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $153 · 2022: $324 · 2023: $2,268 · 2024: $2,026 · 2025: $703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,857 · Travel and Lodging: $2,140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,856.53 |
| Travel and Lodging | $2,140.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,624.52 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Medtronic, INC. | $2,050.63 | 2021-2024 | Hvad Pump Implant Kit |
| Abiomed | $366.77 | 2022-2024 | Impella |
| Pfizer INC. | $117.85 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.09 | 2025 | Jardiance |
| Merck Sharp & Dohme LLC | $103.41 | 2024 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $39.84 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.14 | 2021-2023 | Lifevest |
| Getinge USA Sales, LLC | $14.99 | 2023 | Cardiosave Hybrid, Type B Plug |
| Cvrx, INC. | $14.11 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Geiger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.